Clinical Evaluation of AusDiagnostics SARS-CoV-2 Multiplex Tandem PCR Assay

Overview

Journal J Clin Virol

Specialty Microbiology

Date 2020 May 28

PMID 32460173

Citations 20

Authors

Lucy O Attwood

Michelle J Francis

John Hamblin

Tony M Korman

Julian Druce

Maryza Graham

Affiliations

Soon will be listed here.

Abstract

Background: In the context of the pandemic, the rapid emergency use authorisation of diagnostic assays for SARS-CoV-2 has meant there are few peer-reviewed published studies of clinical performance of commercial assays.

Aims: To evaluate the clinical performance of AusDiagnostics respiratory multiplex tandem PCR assay including SARS-CoV-2.

Methods: We reviewed the results following implementation of AusDiagnostics respiratory multiplex tandem PCR assay including SARS-CoV-2, and compared with an in-house RT-PCR assay at our State Reference Laboratory.

Results: Initial validation using AusDiagnostics coronavirus multiplex tandem PCR assay including SARS-CoV-2 demonstrated good concordance with the State Reference Laboratory. After implementing the AusDiagnostics respiratory multiplex tandem PCR assay including SARS-CoV-2, we tested 7839 samples. 127 samples in which SARS-CoV-2 was detected using the AusDiagnostics assay were referred for testing at the State Reference Laboratory, with concordant results in 118/127 (92.9%) of samples. After resolution of discrepancies, 125/127 (98.4%) of AusDiagnostics results were determined to be true positive results. Out of 7839 samples tested for SARS-CoV-2 during this period, only 2 tests (0.02%) were indeterminate results.

Conclusion: The AusDiagnostics respiratory MT-PCR assay is a reliable assay for detection of SARS-CoV-2.

Citing Articles

Influenza A, Influenza B, human respiratory syncytial virus and SARSCoV-2 molecular diagnostics and epidemiology in the post COVID-19 era.

Lustrek M, Cesar Z, Suljic A, Kogoj R, Knap N, Virant M Respir Res. 2024; 25(1):234.

PMID: 38840154 PMC: 11151539. DOI: 10.1186/s12931-024-02862-7.

Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.

Ramirez M, Zarate M, Rodriguez L, Aquino V PLoS One. 2023; 18(10):e0292314.

PMID: 37797063 PMC: 10553804. DOI: 10.1371/journal.pone.0292314.

Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2.

Karuppaiah G, Vashist A, Nair M, Veerapandian M, Manickam P Biosens Bioelectron X. 2023; 13:100324.

PMID: 36844889 PMC: 9941073. DOI: 10.1016/j.biosx.2023.100324.

Performing under Pressure: Insights into the Diagnostic Testing Burden at a UK National Health Service Clinical Virology Laboratory during the SARS-CoV-2 Pandemic.

Bird P, Taylor G, Cafferata J, Gardener J, McMurray C, Fletcher O Viruses. 2022; 14(10).

PMID: 36298788 PMC: 9609557. DOI: 10.3390/v14102233.

Singleplex, multiplex and pooled sample real-time RT-PCR assays for detection of SARS-CoV-2 in an occupational medicine setting.

Butler K, Carson B, Podlevsky J, Mayes C, Rowland J, Campbell D Sci Rep. 2022; 12(1):17733.

PMID: 36273023 PMC: 9587995. DOI: 10.1038/s41598-022-22106-2.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Nalla A, Casto A, Huang M, Perchetti G, Sampoleo R, Shrestha L . Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit. J Clin Microbiol. 2020; 58(6). PMC: 7269385. DOI: 10.1128/JCM.00557-20. View

Moran A, Beavis K, Matushek S, Ciaglia C, Francois N, Tesic V . Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays. J Clin Microbiol. 2020; 58(8). PMC: 7383516. DOI: 10.1128/JCM.00772-20. View

Cordes A, Heim A . Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion. J Clin Virol. 2020; 125:104305. PMC: 7129486. DOI: 10.1016/j.jcv.2020.104305. View

Rhoads D, Cherian S, Roman K, Stempak L, Schmotzer C, Sadri N . Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19. J Clin Microbiol. 2020; 58(8). PMC: 7383529. DOI: 10.1128/JCM.00760-20. View

Vermeiren C, Marchand-Senecal X, Sheldrake E, Bulir D, Smieja M, Chong S . Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage. J Clin Microbiol. 2020; 58(6). PMC: 7269396. DOI: 10.1128/JCM.00669-20. View

Anderson T, Werno A, Barratt K, Mahagamasekera P, Murdoch D, Jennings L . Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens. J Virol Methods. 2013; 191(2):118-21. PMC: 7119551. DOI: 10.1016/j.jviromet.2013.04.005. View

Poljak M, Korva M, Knap Gasper N, Fujs Komlos K, Sagadin M, Ursic T . Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic. J Clin Microbiol. 2020; 58(6). PMC: 7269406. DOI: 10.1128/JCM.00599-20. View

10.

Kok J, Blyth C, Foo H, Patterson J, Taylor J, McPhie K . Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Microbiol. 2009; 48(1):290-1. PMC: 2812250. DOI: 10.1128/JCM.01465-09. View

11.

Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R . Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020; 212(10):459-462. PMC: 7228321. DOI: 10.5694/mja2.50569. View

12.

Khan S, Siddique R, Shereen M, Ali A, Liu J, Bai Q . Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. J Clin Microbiol. 2020; 58(5). PMC: 7180238. DOI: 10.1128/JCM.00187-20. View

13.

Pfefferle S, Reucher S, Norz D, Lutgehetmann M . Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro Surveill. 2020; 25(9). PMC: 7068162. DOI: 10.2807/1560-7917.ES.2020.25.9.2000152. View

14.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

15.

Ching N, Kotsanas D, Easton M, Francis M, Korman T, Buttery J . Respiratory virus detection and co-infection in children and adults in a large Australian hospital in 2009-2015. J Paediatr Child Health. 2018; 54(12):1321-1328. PMC: 7166960. DOI: 10.1111/jpc.14076. View